Novanta Completes $1.45 Billion Acquisition of Medical Device Firm Riverpoint Medical

Novanta Inc. (NOVT) announced it has completed the acquisition of Riverpoint Medical, a manufacturer of minimally invasive surgical consumables. The transaction, which closed on July 23, 2026, aims to significantly expand Novanta's presence in the medical technology market.

Key Details

• Acquisition Price: The deal includes approximately $1.2 billion in cash paid at closing and a potential $250 million milestone payment due by January 8, 2027.
• Financing: The acquisition was funded with $616 million in borrowings under the company's credit facilities and cash on hand. Following the transaction, Novanta's total consolidated debt stands at $854.7 million.
• Strategic Impact: The acquisition is expected to double Novanta's recurring medical consumables revenue to approximately $300 million and increase its medical end-market exposure to 60% of total revenue. The company anticipates the deal will add $0.18 to $0.25 to adjusted EPS in 2027.